Email Print this page Bookmark this page

Valuable Links

Click here to download a useful tip sheet for patients regarding how to be successful with LACRISERT®. Print out and give to all of your patients receiving a LACRISERT® prescription.

The articles below offer important information about LACRISERT®:

The following Web sites* may be helpful in your treatment of Dry Eye:

  • Medicare Exemption FormMedicare Exemption form for Copay Discount for Medicare patients
  • MedLinePlusProvides a brief outline of Dry Eye and how it may affect you
  • WebMDProvides an in-depth explanation of Dry Eye
  • eMedicineHealthOffers detailed information about Dry Eye
  • The National Eye InstituteProvides information about various eye diseases and disorders that affect Americans, including Dry Eye
  • The Dry Eye ZoneProvides an interactive community offering a discussion forum and other information about Dry Eye
  • Dry Eye Yellow PagesLooking for an eye care professional in your area? The Dry Eye Yellow Pages provides a nationwide list of eye care professionals in one convenient location

Although not specifically focused on Dry Eye, the following links provide helpful information about Sjögren’s syndrome:

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

*Valeant does not endorse the information contained on these Web sites. When you click on these links, you will be leaving the LACRISERT® Web site.

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807